[Controlled clinical study of the effect of combined administration of ethacrynic acid and spironolactone in ascitic liver cirrhosis]
- PMID: 527296
[Controlled clinical study of the effect of combined administration of ethacrynic acid and spironolactone in ascitic liver cirrhosis]
Similar articles
-
[Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].Minerva Nefrol. 1968 Jul-Aug;15(4):258-60. Minerva Nefrol. 1968. PMID: 5745815 Italian. No abstract available.
-
[Comparative study of diuretic drugs used in cirrhotic and ascitic patients].Rev Invest Clin. 1968 Apr-Jun;20(2):165-80. Rev Invest Clin. 1968. PMID: 5721631 Spanish. No abstract available.
-
[Diuretic treatment of hepatic cirrhosis: use of distal diuretics].Rev Clin Esp. 1974 Jan 15;132(1):65-70. Rev Clin Esp. 1974. PMID: 4840230 Spanish. No abstract available.
-
Refractory oedema.Br J Hosp Med. 1980 Mar;23(3):225, 228, 230-2 passim. Br J Hosp Med. 1980. PMID: 6991043 Review. No abstract available.
-
[Hyperaldosteronism, spironolactone and liver cirrhosis].Gastroenterol Hepatol. 1997 Mar;20(3):151-9. Gastroenterol Hepatol. 1997. PMID: 9162537 Review. Spanish. No abstract available.
Cited by
-
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD013123. doi: 10.1002/14651858.CD013123.pub2. Cochrane Database Syst Rev. 2020. PMID: 31978257 Free PMC article.